A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer - Concepedia

Concepedia

Publication | Closed Access

A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer

32

Citations

29

References

2018

Year

Tomotaka Saito, Yousuke Nakai, Hiroyuki Isayama, Kenji Hirano, Kazunaga Ishigaki, Ryunosuke Hakuta, Tsuyoshi Takeda, Kei Saito, Gyotane Umefune, Dai Akiyama,

Abstract

In this randomized controlled trial, pancrelipase failed to improve the change in BMI at 8 weeks in PC patients receiving chemotherapy.

References

	Year	Citations

Page 1